To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Whipps Cross Hospital: Construction
Wednesday 24th July 2024

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse of rebuilding Whipps Cross Hospital; and what his expected timetable is for when this funding will be made available to Barts Health NHS Trust.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Government recognises the immediate issues affecting the National Health Service and is determined to fix them. We also recognise the need for investment in our estate across the country, including at Whipps Cross University Hospital, North East London.

My Rt. Hon. Friend, the Secretary of State for Health and Social Care, has asked for an urgent report on the degree to which the New Hospital Programme is funded and a realistic timetable for delivery. He will consider this carefully then report back to patients, clinicians and local communities to confirm revision, if any, to the schedule.


Written Question
Pancreatic Cancer: Medical Treatments
Monday 20th May 2024

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that patients taking pancreatic enzymes continue to receive them.

Answered by Andrew Stephenson

We are aware of supply issues with three pancreatic enzyme replacement therapies: Creon 10000 gastro-resistant capsules; Creon 25000 gastro-resistant capsules; and Nutrizym 22 gastro-resistant capsules. We understand that these are due to limited availability of active pharmaceutical ingredients, and manufacturing constraints in producing the volumes required to meet demand. The Department has issued guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products, to ask that they expedite deliveries and increase production forecasts, and to confirm that they are taking action to address the root causes of the issues, to ensure continuity of supply. We are also working with specialist importers to source unlicensed imports from abroad.

Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.


Written Question
Sexual Assault Referral Centres
Monday 18th December 2023

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many patients were (a) seen and (b) treated by NHS commissioned Sexual Assault Referral Centres run by Mountain Healthcare in each financial year since 2018-19.

Answered by Maria Caulfield

The following table shows the number of patients were seen by National Health Service-commissioned sexual assault referral centres (SARCs) run by Mountain Healthcare in each financial year since 2018/19:

Year

Number of patients seen

2018/19

4,689

2019/20

3,240

2020/21

2,080

2021/22

3,742

2022/23

10,822

Source: NHS England

Notes:

  1. The numbers of patients ‘seen’ and the numbers of patients ‘treated’ are the same, as all SARC attendances receive a form of treatment.
  2. Data was submitted manually prior to 2022/23. This required providers to record aggregated numbers against indicators and can be unreliable.
  3. The 2019/20 data is reported to December 2019. Due to COVID-19, the data between January and March 2020 was not collected or reported.

Written Question
Sexual Assault Referral Centres
Monday 18th December 2023

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many patients were (a) seen and (b) treated by NHS commissioned Sexual Assault Referral Centres in each financial year since 2018-19.

Answered by Maria Caulfield

The following table shows the numbers of patients seen by National Health Service-commissioned sexual assault referral centres (SARCs) in each financial year since 2018/19:

Year

Number of patients seen by SARCs

2018/19

11,993

2019/20

9,451

2020/21

7,960

2021/22

10,333

2022/23

21,836


Source: NHS England

Notes:

  1. The numbers of patients ‘seen’ and the numbers of patients ‘treated’ are the same, as all SARC attendances receive a form of treatment.
  2. Data was submitted manually prior to 2022/23. This required providers to record aggregated numbers against indicators and can be unreliable.
  3. The 2019/20 data is data reported up to December 2019. Due to COVID-19, data for January to March 2020 was not collected or reported.


Written Question
Sexual Assault Referral Centres
Monday 18th December 2023

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many patients were (a) seen and (b) treated by NHS commissioned Sexual Assault Referral Centres run by G4S Health Services in each financial year since 2018-19.

Answered by Maria Caulfield

The following table shows the number of patients seen by National Health Service-commissioned sexual assault referral centres (SARCs) run by G4S Health Services in each financial year since 2018/19:

Year

Number of patients seen

2018/19

1,728

2019/20

1,256

2020/21

1,479

2021/22

1,439

2022/23

1,625

Source: NHS England

Notes:

  1. The numbers of patients ‘seen’ and the numbers of patients ‘treated’ are the same, as all SARC attendances receive a form of treatment.
  2. Data was submitted manually prior to 2022/23. This required providers to record aggregated numbers against indicators and can be unreliable.
  3. The 2019/20 data is reported up to December 2019. Due to COVID-19, data between January and March 2020 was not collected or reported.

Written Question
Health Services: Police Custody
Wednesday 29th November 2023

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how much NHS England paid to (a) Mountain Healthcare Ltd and (b) G4S Health UK Ltd for the provision of healthcare in police custody and secure environments between (i) October 2020 to September 2021 and (ii) October 2021 to September 2022.

Answered by Maria Caulfield

NHS England does not have responsibility for healthcare provision within police custody, as this sits with police commissioners and the Home Office.

Regarding payments to Mountain Healthcare Ltd and G4S Health UK Ltd for provision within the detained estate, NHS England has advised that figures are not available of the timeframes requested, as its financial accounting and reporting year runs from April to March. It can confirm that G4S Health UK received £4.05 million between 1 April 2020 and 31 March 2021, and £2.495 million between 1 April 2021 to 31 March 2022 for health care in the detained estate. No payments were made to Mountain Healthcare during these periods.


Written Question
Sexual Assault Referral Centres: Finance
Wednesday 29th November 2023

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how much NHS England paid for the provision of sexual assault referral services in the financial years (a) 2020-21, (b) 2021-22 and (c) 2022-23.

Answered by Maria Caulfield

The following table shows the amounts paid by NHS England for the provision of Sexual Assault and Abuse Services over the past three financial years:

Financial Year

Amount (£)

2020/21

38,998,000

2021/22

42,331,000

2022/23

48,090,000

Source: NHS England


Written Question
Sexual Assault Referral Centres: Finance
Wednesday 29th November 2023

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how much NHS England paid for the provision of sexual assault referral services to (a) Mountain Healthcare Ltd and (b) G4S Health UK Ltd between (i) October 2020 to September 2021 and (ii) October 2021 to September 2022.

Answered by Maria Caulfield

The information is not held in the format requested as NHS England's financial accounting and reporting is from April to March. The following table shows the amounts paid to both Mountain Healthcare Ltd and G4S Health UK Ltd over the past three financial years, for the provision of sexual assault referral services:

Financial Year

Amount paid to Mountain Healthcare Ltd (£)

Amount paid to G4S Health UK Ltd (£)

2020/21

4,431,000

4,406,000

2021/22

8,073,000

4,124,000

2022/23

10,911,000

5,076,000

Source: NHS England


Written Question
NHS: Training
Thursday 26th October 2023

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how much his Department spent on the (a) Childcare Allowance (b) Parent Learning Allowance and (c) Dependent's Allowance of the NHS Bursary; and how many people have (i) made a claim and (ii) been eligible for support under that scheme in each of the last five years.

Answered by Will Quince

Prior to 2017, the NHS Bursary was available to nursing, midwifery and allied health professions students as well as medical and dental students. Nursing, midwifery and allied health professions students starting courses after 2017 were transitioned on to the Student Finance loans system and the NHS Learning Support Fund.

The following table shows for the years 2018/19 to 2022/23 the number of students who received an element of NHS Bursary, together with the number of students who received available childcare components and their corresponding expenditure.

Financial Year

2018/19

2019/20

2020/21

2021/22

2022/23*

Number of Students who Received an Element of Funding

67,748

43,470

20,147

17,289

18,076

Number of Students in Receipt of Dependants Allowance

9,178

5,050

1,096

357

247

Dependants Allowance Expenditure (£)

19,053,850

8,344,526

1,599,887

539,752

363,775

Number of Students in Receipt of Parent Learning Allowance

9,141

5,033

1,077

332

179

Parent Learning Allowance Expenditure (£)

7,846,287

3,417,731

653,253

211,489

103,489

Number of Students in Receipt of Childcare Allowance

5,031

2,557

576

144

83

Childcare Allowance Expenditure (£)

16,659,222

7,028,750

1,313,955

399,834

238,972

Source: NHS Business Services Authority

Note: The NHS Business Services Authority moved to a new system in 2022/23. The student count is from two different IT systems with no unique identifier, with potential for duplication in the count. Financial values are unaffected.


Written Question
Coronavirus and Influenza
Tuesday 24th October 2023

Asked by: Stella Creasy (Labour (Co-op) - Walthamstow)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what stocks NHS England has of (a) covid-19 boosters, (b) covid-19 rapid tests, (c) N95 masks and (d) flu vaccines as of October 2023, in the context of preparations for winter 2023-24.

Answered by Maria Caulfield

COVID-19 vaccines are purchased by the UK Health Security Agency (UKHSA). NHS England manages the distribution of stock to the front-line. At the beginning of the autumn/winter campaign, NHS England had access to 14.5 million doses of applicable vaccines, to meet the needs of the eligible cohorts as advised by the Joint Committee on Vaccination and Immunisation. NHS England also has stocks of 1,509,200 COVID-19 rapid tests and 114,061,080 FFP3 respirators.

NHS England does not centrally procure or stock any adult flu vaccines. General practitioners and other providers are responsible for ordering adult flu vaccine directly from suppliers, which are used to deliver the national flu programme to the other eligible groups.

Children’s flu vaccines are centrally procured and distributed by UKHSA. We are unable to provide specific stack levels as this information is commercially sensitive but there are adequate stocks of the live attenuated vaccine.